PCIB

AcronymDefinition
PCIBPremier Commercial and Industrial Builders (Australia)
PCIBPermanent Community Impact Board (Utah)
PCIBPublic Complaints Investigation Bureau (Canada)
PCIBPhilippine Commercial and International Bank (Philippines)
PCIBP-Chloroiodobenzene
PCIBProtocol Control Information Bus (IEEE P1386.1)
PCIBparachlorophenoxy isobutyric acid
References in periodicals archive ?
Pacita Juan, PCIB president and cochair, said, 'This festival is just one of three outcomes of a presidential order in 2002 to uplift the coffee industry.'
The PCIB, an advocacy group for the country's biggest coffee roasters, is appealing to the Department of Trade and Industry to step in, and maybe, intervene in the bracketing of prices of roasted and ground coffee products, both local and imported, sold in supermarkets and grocery stores.
Two plant growth retardants (PGRs) were applied; PBZ and PCIB (secured from Genotech Co., Egypt).
Sobre la zona proximal del pedicelo de cada fruto identificado se aplico 2 [micron]mol disueltos en 0,1 g de pasta de lanolina de uno de los siguientes compuestos (tratamientos): inhibidor de la actividad auxinica (antiauxina): acido 2-(pclorofenoxi)-2-metilpropionico (PCIB); inhibidores del transporte polar de auxinas: acido 2,3,5 triiodobenzoico (TIBA) y acido 2-cloro-9hidroxifluorene-9-carboxilico (HFCA).
PCIB Chair Nicholas Matti gathered the biggest roasters in the country to consolidate their efforts to keep coffee prices stable in supermarkets and groceries.
PCIB Securities, a securities dealer and broker with a seat in the Philippine Stock Exchange, will be renamed BDO Nomura Securities Inc.
19 February 2010 - Norwegian biopharmaceutical company PCI Biotech Holding ASA (OSL: PCIB) said today its net loss shrank to NOK3.6m in the fourth quarter of 2009 from NOK8.4m in the same period in 2008, according to preliminarily figures.
19 January 2010 - Norwegian biopharmaceutical company PCI Biotech Holding ASA (OSL: PCIB) said today that strong anti-tumour response was observed in all patients from the second dose group in the phase I/II study of its proprietary photosensitiser Amphinex.
The top three small brokers were Armstrong Securities, Tri-State Securities and PCIB Securities.
19 January 2010 - Norwegian biotechnology firm PCI Biotech Holding ASA (OSL: PCIB) said today it has successfully completed the treatment of the second dose group in the Phase I/II study of its photosensitiser Amphinex used in combination with the cytotoxic agent bleomycin in cancer patients.
3 December 2009 - Norwegian biopharmaceutical company PCI Biotech Holding ASA (OSL: PCIB) announced today the start of pre-clinical trials for the use of Photochemical Internalisation (PCI) in the treatment of bladder cancer.
27 October 2009 - Norwegian biopharmaceutical company PCI Biotech Holding ASA (OSL: PCIB) posted today a net loss of NOK3.3m for the third quarter of 2009, in comparison with a loss of NOK2.6m a year earlier.